A 61-year-old male is given acetazolamide to treat open-angle glaucoma. Upon diuresis, his urine is found to be highly alkaline. Which of the following accounts for the alkaline nature of this patient’s urine?

Inhibition of bicarbonate reabsorption in the proximal tubule

Inhibition of bicarbonate reabsorption in beta-intercalated cells

Inhibition of acid secretion in alpha-intercalated cells

Inhibition of chloride reabsorption in the distal convoluted tubule

Inhibition of chloride reabsorption in the thick ascending loop of Henle

A 72-year-old woman presents to the clinic complaining of diarrhea for the past week. She mentions intense fatigue and intermittent, cramping abdominal pain. She has not noticed any blood in her stool. She recalls an episode of pneumonia last month for which she was hospitalized and treated with antibiotics. She has traveled recently to Florida to visit her family and friends. Her past medical history is significant for hypertension, peptic ulcer disease, and hypercholesterolemia for which she takes losartan, esomeprazole, and atorvastatin. She also has osteoporosis, for which she takes calcium and vitamin D and occasional constipation for which she takes an over the counter laxative as needed. Physical examination shows lower abdominal tenderness but is otherwise insignificant. Blood pressure is 110/70 mm Hg, pulse is 80/min, and respiratory rate is 18/min. Stool testing is performed and reveals the presence of anaerobic, gram-positive bacilli. Which of the following increased this patient’s risk of developing this clinical presentation?

Recent antibiotic use for pneumonia treatment

Hypercholesterolemia treated with atorvastatin

Constipation treated with laxatives

Osteoporosis treated with calcium and vitamin D

Peptic ulcer disease treated with esomeprazole

A 76-year-old man comes to the physician for a follow-up examination. One week ago, he was prescribed azithromycin for acute bacterial sinusitis. He has a history of atrial fibrillation treated with warfarin and metoprolol. Physical examination shows no abnormalities. Compared to one month ago, laboratory studies show a mild increase in INR. Which of the following best explains this patient's laboratory finding?

Increased gastrointestinal absorption of warfarin

Increased non-protein bound warfarin fraction

A 45-year-old woman presents to the emergency department with fever, cough, tonsillar enlargement, and bleeding lips. She has a diffuse blistering rash that encompasses the palms and soles of her feet, in total covering 55% of her total body surface area (TBSA). The upper epidermal layer easily slips away with slight rubbing. Within 24 hours the rash progresses to 88% TBSA involvement and the patient requires mechanical ventilation for respiratory distress. Which of the following is the most likely etiology of this patient’s condition?

Deficiency of C-1 esterase inhibitor

Pharmacokinetic interaction mechanisms for USMLE Step 3: High-Yield Pharmacology Lessons

Absorption Interactions - First-Pass Fumbles

Altered Gut Lumen Chemistry:
- Chelation: Drugs bind in the gut, preventing absorption.
  - Example: Tetracyclines or fluoroquinolones + divalent cations (Ca²⁺, Mg²⁺, Fe²⁺) in antacids or dairy.
- Altered pH: Changed stomach acidity impairs absorption of pH-dependent drugs.
  - Example: ↓ absorption of ketoconazole (needs acid) with proton pump inhibitors (PPIs).
Altered Gut Motility:
- ↑ Motility: Less time for absorption (e.g., metoclopramide ↓ digoxin absorption).
- ↓ Motility: More time for absorption (e.g., anticholinergics ↑ digoxin absorption).
Gut Wall Metabolism (First-Pass Fumbles):
- Inhibition of enzymes in the gut wall (e.g., CYP3A4) increases bioavailability.
⭐ Grapefruit juice is a potent inhibitor of intestinal CYP3A4, significantly increasing levels of drugs like statins and calcium channel blockers, risking toxicity.

Grapefruit juice interaction with felodipine and CYP3A4

Distribution Interactions - Protein Binding Battles

Mechanism: A highly protein-bound drug is displaced from plasma proteins (e.g., albumin) by another drug. This ↑ the free (active) concentration of the displaced drug.
Equation: $Drug_{bound} ightleftharpoons Drug_{free} + Protein$
High-Risk Drugs: Those with >90% protein binding and a narrow therapeutic index.
- Examples: Warfarin, Phenytoin, Methotrexate, Sulfonylureas.
Classic Interaction: Sulfonamides or Aspirin displace Warfarin, leading to ↑ free Warfarin and ↑ bleeding risk.

Reversible drug binding to albumin and retention

⭐ High-Yield Fact: The increase in free drug concentration is often transient. The newly freed drug is also more available for metabolism and excretion, which can lead to a new, lower total drug concentration steady-state over time.

Metabolism Interactions - CYP450 Power Plays

Cytochrome P450 (CYP450) enzymes are a major source of pharmacokinetic drug interactions. Modulating their activity can drastically alter drug concentrations, leading to toxicity or therapeutic failure.

Enzyme Inhibition Mechanisms

CYP450 Inducers (↓ Drug Levels)	CYP450 Inhibitors (↑ Drug Levels)
Effect: Accelerate metabolism, ↓ substrate drug levels, potentially causing therapeutic failure.	Effect: Slow metabolism, ↑ substrate drug levels, potentially causing toxicity.
Examples:	Examples:
* Rifampin	* Macrolides (e.g., Erythromycin)
* Phenobarbital	* Azole antifungals (e.g., Ketoconazole)
* Carbamazepine	* Grapefruit juice
* St. John's Wort	* Protease Inhibitors (e.g., Ritonavir)
📌 Mnemonic: CRAP GPS (Carbamazepine, Rifampin, Alcohol (chronic), Phenytoin, Griseofulvin, Phenobarbital, Sulfonylureas)	📌 Mnemonic: SICKFACES.COM (Sodium valproate, Isoniazid, Cimetidine, Ketoconazole, Fluconazole, Alcohol (acute), Chloramphenicol, Erythromycin, Sulfonamides, Ciprofloxacin, Omeprazole, Metronidazole)

Excretion Interactions - Kidney's Gatekeepers

Competition for Renal Transporters: Drugs can compete for active secretion into the renal tubules, primarily via Organic Anion Transporters (OATs) and Organic Cation Transporters (OCTs) in the proximal tubule.
- Example: Probenecid ↓ renal clearance of Penicillin by inhibiting OAT-mediated secretion, thus ↑ its plasma concentration and half-life.
Alteration of Urine pH (Ion Trapping): Modifying urine pH changes the ionization state of weak acids/bases, affecting their reabsorption.
- Weak Acids (e.g., Aspirin, Phenobarbital): Alkalinize urine with sodium bicarbonate ($HCO_3^−$) to ↑ excretion. $HA \rightleftharpoons H^+ + A^-$. Traps drug in its ionized, water-soluble form ($A^-$).
- Weak Bases (e.g., Amphetamines): Acidify urine (e.g., with ammonium chloride, $NH_4Cl$) to ↑ excretion.

⭐ For salicylate (aspirin) toxicity, administer sodium bicarbonate to alkalinize the urine, which promotes ion trapping and enhances renal excretion.

High‑Yield Points - ⚡ Biggest Takeaways

CYP450 enzyme induction (e.g., rifampin) ↓ drug levels, while inhibition (e.g., grapefruit juice, azoles) ↑ toxicity.

P-glycoprotein (P-gp) inhibition ↑ drug absorption and bioavailability; induction does the opposite.

Altered absorption occurs via chelation (tetracyclines + iron) or gastric pH changes (antacids).

Displacement from plasma proteins (e.g., warfarin) ↑ free drug concentration and toxicity risk.

Altering urinary pH modifies the renal clearance of weak acids/bases (e.g., aspirin).

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play